Antibody-Mediated Beta-Cell Protection for the Treatment of Type-2 Diabetes

• Unité de recherche: INNOSUISSE
• Numéro de projet: 17448.1 PFLS-LS
• Titre du projet anglais: Antibody-Mediated Beta-Cell Protection for the Treatment of Type-2 Diabetes

Description succincte (Allemand)

Antibody-Mediated Beta-Cell Protection for the Treatment of Type-2 Diabetes

Description succincte (Anglais)

Antibody-Mediated Beta-Cell Protection for the Treatment of Type-2 Diabetes: MIP: Neurimmune

Résumé des résultats (Abstract) (Allemand)

The project is aimed at elucidating the mechanism of action of a newly developed disease-modifying immunotherapy for type-2 diabetes, along with the identification of biomarkers for patient selection and monitoring of the clinical response. The resulting data package will allow for the progression of this experimental therapy towards clinical development and partnering with a major biopharmaceutical company.

Résumé des résultats (Abstract) (Anglais)